Genitourinary Cancer,RCC (Renal Cell Carcinoma) Pembrolizumab Plus Lenvatinib as First-Line Treatment for nCRCC Jun 02, 2023
Genitourinary Cancer,Prostate Cancer Nivolumab Plus Docetaxel in Chemotherapy-Naïve mCRPC: CheckMate 9KD Trial Results Jun 01, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Cabozantinib Plus Nivolumab Shows Promise in Non-clear-Cell Renal Cell Carcinoma May 30, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) CTX130: A Promising Treatment Option for Relapsed or Refractory Renal Cell Carcinoma in COBALT-RCC Study May 30, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Concurrent and Adjuvant Durvalumab With Chemoradiotherapy in Advanced Cervical Cancer May 22, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Molecular Profiling of Circulating Tumor Cells in mRCC Over Time May 22, 2023
Genitourinary Cancer,Prostate Cancer COMET-2 Trial: Treatment Tolerance With Patient-Reported Outcomes Data and Toxicity Index Evaluated May 03, 2023
Genitourinary Cancer,Prostate Cancer A Phase 2 Study on Oral Docetaxel + Ritonavir for mCRPC May 03, 2023
